Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Classement en actions #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Prix de l'action
$0.21291741
Dernière synchronisation: 2025-04-18
Capitalisation boursière
$12.07M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
KR
Échange PCL, Inc. (241820)

Catégorie

Ratio P/B pour PCL, Inc. (241820)
Ratio P/B au August 2026 TTM : 0.31
Selon les derniers rapports financiers et le cours de l'action de PCL, Inc., le ratio cours/valeur comptable actuel (TTM) est 0.31. À la fin de 2023, le ratio P/B était de 4.33.
Historique du ratio P/B pour PCL, Inc. de 2015 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.31 -92.92%
2024 4.37 0.92%
2023 4.33 -22.84%
2022 5.61 -79.76%
2021 27.74 158.91%
2020 10.71 -23.63%
2019 14.03 43.20%
2018 9.80 -11.87%
2017 11.12 -9.46%
2016 12.28 -33.14%
2015 18.36 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.7944 1,126.37%
US
5.423 1,652.75%
US
2.0146 551.13%
IE
3.072 892.89%
US
4.9725 1,507.14%
US